Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AVXL has no evidence that it works on any AD patients. They have run no valid controlled trials, and their current scam conducted in AUS only, only addresses MCI patients which a large % never develop AD.
You are right, AVXL is a scam, that's why they have to data mine results inorder to spin there next pump.
"My concern, if I owned AVXL, would be that this class of drug (S1R) has failed well-controlled large-scale trials in AD. "
AVXL is about science fiction.
They don't have a legitimate AD trial, they don't even have a valid patent for there drug in US. The lame trial they are running in AUS is for MCI not AD.
BR, everything in that article is documented. Ignoring facts and attacking the messenger does not find the truth IMO. All of Fontaneu's claims are based on documented facts. Most directly from AVXL's SEC filings. Now the corrupt AVXL management is doing another pump and dump.
That is rich, so the FDA is now being manipulated into giving breakthrough designation to a company, I see the scam that AVXL is. LOL
No it is all about the money with AVXL, NTRP has the science, AVXL is a scam to extract money from retail investors.
Documented evidence:
"From 2006 until 2013, while it is unclear if and when any real drug development seemed to have taken place, Anavex always kept with its habit of regularly releasing optimistic PR updates, but the stock kept drifting lower and lower until the Spring of 2013, when a new episode of paid promotional activity seemed to have taken place as exhibited by this notice from the British Columbia Securities Commission circulated after it had ordered the suspension of trading in Anavex shares following unusual activity and reports of paid promotions. "
https://medium.com/@jfindallas/the-secret-to-making-2000-in-stocks-overnight-the-anavex-story-342be9c7e5e6
There is no documentation on founders stock given to Dr Missleading, but it if true it explains why the company appears to be all about him making money,
"As far as one can tell Fontenau is a shill for market manipulators"
I dont see that person warning stock holders and showing how a stock is being manipulated can be called a manipulator. It is not like he is on multiple boards promoting or bashing stocks every day.
I would think with the credibility of Dr Alkon and the fact that we are the only company addressing severe AD, getting this would be a resonable assumption if the results are as expected. Here is the FDA description.
"About FDA Breakthrough Therapy Designation"
Breakthrough Therapy designation is granted by the FDA in order to expedite the development and review of drugs for serious or life-threatening conditions. In order to receive Breakthrough Therapy designation, a drug must demonstrate preliminary clinical evidence that the drug may have substantial improvement on at least one clinically significant endpoint over available therapy. Breakthrough Therapy designation provides an organizational commitment involving senior managers from the FDA, more intensive FDA guidance on an efficient drug development program, and greater access to and more frequent communication with the FDA throughout the entire drug development and review process. It also provides the opportunity to submit sections of a New Drug Application (NDA) on a rolling basis, where the FDA may review portions of the NDA as they are received instead of waiting for the entire NDA submission. In addition, Breakthrough Therapy designated products are eligible for Priority Review, where the FDA has a goal to take action on an application within six months, as opposed to ten months under standard review. Breakthrough Therapy designation does not change the standards for approval.
That's good that you think you know what you are doing. There has been a lot of hype on different msg boards about AVXL and that is what the article shows that they did last time. Promises of big rewards get people to over buy into these scams.
No, anyone can do pre-clinical trials and publish resluts, there is no data published from Anavex's small non placebo based AD trial that ran for 5 years. Now they are claiming that they will have results in 2 years. Plenty of time to scam retail investors. Hope you dont lose more than you can afford.
AVXL has never published any peer reviewed results for any trial. They are running their AD trial outside of the US because they cant get it accepted here. The link is based on facts from the companies SEC filings.
Do your own DD dont believe whats posted on msg boards. No retail investors have made money only the CEO, pr person and LPC.
Beware Anavex is continuing its retail investor scam. Starting another AMT deal and about to dilute even more with new issue of Preferred stock.
Same game as documented here.
https://medium.com/@jfindallas/the-secret-to-making-2000-in-stocks-overnight-the-anavex-story-342be9c7e5e6
"After studying the history of Anavex from its inception to today, it appears in my opinion, that the only business Anavex Life Sciences has really ever been in, has been the business of filing, issuing and selling new shares of little to no value to the unsuspecting public, on that count it seems to have been an extremely successful venture"
The facts dont lie, it is all verified from their SEC filings. Fact is it is a retail investor rip-off scheme. Looks to me they are going for round three. Anavex Investors beware.
https://medium.com/@jfindallas/the-secret-to-making-2000-in-stocks-overnight-the-anavex-story-342be9c7e5e6
"In this current incarnation Anavex Life Sciences appears to be very generous with its management, namely the CEO, according to the company filing here, Anavex Lifesciences CEO was awarded compensation worth $2.66 million for the year 2013 and $650,000 for the year 2014, a level of compensation on par with what CEOs in the sector are paid for jobs at companies employing tens if not hundreds of employees. In any case this sounds extremely high for such a small venture or a biotech startup. As far as one can tell it appears that in 2013 and for at least part of 2014 the CEO was the only full time employee of Anavex Life Sciences, so it seems that he was extremely well compensated for the job of managing himself."
Yes, amazing but not surprising. The mangement and the science is suspect. It's just another retail investor ripoff.
https://medium.com/@jfindallas/the-secret-to-making-2000-in-stocks-overnight-the-anavex-story-342be9c7e5e6
"In this current incarnation Anavex Life Sciences appears to be very generous with its management, namely the CEO, according to the company filing here, Anavex Lifesciences CEO was awarded compensation worth $2.66 million for the year 2013 and $650,000 for the year 2014, a level of compensation on par with what CEOs in the sector are paid for jobs at companies employing tens if not hundreds of employees. In any case this sounds extremely high for such a small venture or a biotech startup. As far as one can tell it appears that in 2013 and for at least part of 2014 the CEO was the only full time employee of Anavex Life Sciences, so it seems that he was extremely well compensated for the job of managing himself.
Equally at more than $2,000,000+ for the year 2014, the level of “General & Administrative Expenses” seems also incredibly high for a venture with even 5 employees, and even taking into account the fact that Anavex rents offices at a very expensive address in the famous CBS building(some ventures often like to setup shop in the most prestigious addresses and have a lot of fancy titles in the hope it will help compensate for the lack of substance). Given the fact that the company seemed to have only 1 full time employee for most of 2014, the CEO job must also come with some very enviable perks.
(On Saturday, November 7, 2015, Anavex Life Sciences presented the trial data that was advertised has revolutionary and groundbreaking in the promotion referenced at the beginning of this article, and was portrayed as the starting point of miraculous gains, I will refrain from commenting on the data at length since a number of people have already given opinions and from what I can gather it appears to have shown not statistically significant results and a flawed trial(a very small “n” called Phase2 trial(while designed like a Phase1) that was unblinded and had no placebo control arm.))
In my opinion the trial was successful in its main purpose: creating a run-up in the stock price and give some material for coordinated promotion operations.
To conclude, Anavex Life Sciences(AVXL), appears to be somewhat of a phenomenon in the world of stock promotion schemes for its longevity, sophistication and scale.
In an era where unprecedented amounts of funds are, and have been flowing into the biotechnology sector over the past 5 years, chasing any investment opportunity/asset with the slightest chance of success, it seems very unlikely that any asset holding a possible chance at a major breakthrough in the treatment of Alzheimer’s disease(an obviously very large market) would be left drifting and dormant for someone to come around and pick it up for pennies."
Failed science, LOL, what failed science is Anavex Plus, how much did they spend on getting a worthless patent that is the only one they have for AD. Was that a hail Mary or a failed pump IYO.
I think people forget that most investors and institution's don't like risk. They would rather have confirmation of results when the price is $20 going to $100 rather then $5 going to $20.
You mean the same people that have been fooled by all of the previous AD drugs that failed. My guess is that they have nothing to lose so why not take the money, then be the expert on why it failed later.
Beware Anavex is continuing its retail investor scam. Starting another AMT deal and about to dilute even more with new issue of Preferred stock.
Same game as documented here.
https://medium.com/@jfindallas/the-secret-to-making-2000-in-stocks-overnight-the-anavex-story-342be9c7e5e6
"After studying the history of Anavex from its inception to today, it appears in my opinion, that the only business Anavex Life Sciences has really ever been in, has been the business of filing, issuing and selling new shares of little to no value to the unsuspecting public, on that count it seems to have been an extremely successful venture"
Coach, I dont know, AVXL smells real bad to me. The things listed in that article are all true and verifiable. I agree that the only things that matter are results. So why would a legitimate company that has been touting an AD trial since 2009 and has raised more investor money than NTRP, still has not have completed one with a placebo arm? And is now claiming it is because they are adopting "precision medicine". The article talks about how all of the related msg boards were bombarded with AVXL claims, is that not what is happening to this board now? What makes sense to me is this conclusion below from the article. The same thing is happening as we speak, a new AMT deal and the authorizing of millions of Preferred stock. It makes sense if issuing stock is your goal and to not complete trials to soon.
"After studying the history of Anavex from its inception to today, it appears in my opinion, that the only business Anavex Life Sciences has really ever been in, has been the business of filing, issuing and selling new shares of little to no value to the unsuspecting public, on that count it seems to have been an extremely successful venture…"
As documented before a good scammer like Dr Missleading finds it easy to fool people, especially when they are getting paid. He has been missleading people even before he became the unqualified CEO that he is. The company has not completed a single valid trial and keeps releasing data with no peer review. They are two years away from doing so per their own stated schedule, and they have never ever met a schedule they have set. Who would believe that they will ever complete anything?
Making ridiculous statements like that only put a big red flag on the credibility of Avanex. It has gotten in trouble before for using those tactics.
The rise, fall and rebirth of Anavex Life Sciences, a ghost from the past preying on people’s hope.
https://medium.com/@jfindallas/the-secret-to-making-2000-in-stocks-overnight-the-anavex-story-342be9c7e5e6
"They were contractually forbidden to short or hedge. It was the Street Walkers from Wall Street that orchestrated "a falling AVXL stock price". "
That is not true, and do you think LPC is part of the cabal that causes the AVXL stock to drop?
So that's why AVXL stock has been tanked for the past 18 months? Or is it mainly the LPC ongoing dilution.
"As of December 31, 2018, loss per share excludes 7,877,145 (September 30, 2018 – 7,185,296) potentially dilutive common shares related to outstanding options and warrants, as their effect was anti-dilutive."
So you are referring to the failure of 2-73 as a cancer drug. You also must be referring to LPC, the only people who continued to make money on a falling AVXL stock price.
So a non profit committed to AD research got some govt grants and that is somehow "old" shady money. Nothing in your post other than your opinion is a negative for the stock. The statement that research failed is a total lie and it really goes to the heart of the post not having any credibility at all.
Dont know, first time I noticed it happening.
Is my level screwy or what, the BId is at 5.07 andthe ask is at 4.98?
This post is a total fabrication and distortion of the facts. For a real analysis of the company see the following.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147738729
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145496445
Also see the links posted above. Do your own DD and not rely on mis information.
Coach thanks for doing everyone a favor and keeping the facts straight. It's obvious from your comparison what the truth is.
That argument is priceless, when 2-73 fails, the company can spin the precision medicine claim. That is what a company does that is trying to flece investors IMO.
Yes, it is hard to put much faith in a company when you have to speculate about their IP. It does make it easier for Dr Missleading thou.
That's funny look at all of the companies whose SAB's he is on, the trend is their companies trials fail. Look it up it us interesting
Makes sense to me, 2-73 is a sleeping pill. Dr Alkon not only explained it he predicted it.
LOL, no peer review only paid consultants.
That is total BS, over $300m in research funds invested by non profit setup to research AD. It was not something that was invented by a Greek goat herder and sold to a Canadian photo finishing shop. CRE group owns less than 1% of outstanding stock and is part of UWVA research group. I can't wait to see the massive dilution of AVXL and the spin from Dr Missleading.
You are correct, but given we are the only game in town for treating severe AD, vs MCI with a high no of misdiagnosis, I think there is a good chance of something before 2022.
How does that matter, the results will speak for themselves. We will know in 5 months, it will be two years before AVXL has any meaningful results, Good Luck.
What I hear you saying is that if WS now embraces NTRP somehow that validates the science.
Per Dr Alkon, full trials will not be necessary. The requirement for bio equivalency is fairly straight forward. Per the real Dr, it will not be a problem.
Market cap has nothing to do with it, if it did Biogen would already have it solved. Suggest you listen to the sticky interview with a real Dr. We will know in a few months rather than a few years.
Coach, the part of the audio I liked was where Dr Alkon stated that the early stage studies which include MCI patients, have patients that do not even have AD. Reconfirms to me why these "early" stage trials will go no where.